Unsure which shares to buy?
The Money Show's Bruce Whitfield interviewed Nadim Mohamed, Investment Analyst at First Avenue Investment Management.
Mohamed reckons you need not look further than these three companies:
-
Dis-chem
-
Richemont
- Microsoft
For more detail; listen to the interview in the audio below.
Get the 10 most-read articles of the week from Bruce Whitfield’s The Money Show, emailed to you every Friday morning:
Read More
The Money Show’s Bruce Whitfield asks Peter Armitage (CEO at Anchor Capital) for his stock picks of the week.
Can you afford to leave South Africa? Certified Financial Planner (CFP) Barry O'Mahony on what to consider before deciding.
Edgar Mafoko (Portfolio Manager at FNB Wealth and Investments) shares his stock picks of the week on The Money Show.
Got R50? No? Got R5? Personal finance expert Warren Ingram on how to buy shares with tiny amounts of money.
The JSE is struggling. The rand is toast. Trump’s trade war has markets rattled. Advisor Warren Ingram discusses places of safety.
Not sure which shares to buy? Bruce Whitfield interviews Gerbrand Smit, Chief Investment Officer at Nefg Fund Managers.
Popular articles
The newly elected president of the Black Management Forum (BMF) is Andile Nomlala.
Wendy Knowler, consumer journalist, on the importance of carefully reading your documents when you buy assets.
Google has not only indexed the internet, but they have also mapped the world
Annual consumer price inflation increased at a faster rate of 4.5% in January, compared to 4% in December.
South Africa's Grand Parade Investments (GPI) Ltd will sell its 95.36 percent stake in the Burger King franchise.
Thuli Mpetsheni says she does not know the circumstances surrounding her son's detainment but it appears his visa has expired.
SAA returned to Parliament on Wednesday to brief public finance watchdog Scopa on its state of affairs.
ABC leader and Lesotho Prime Minister Tom Thabane has announced twice that he will retire with no time specified.
Discovery Health CEO Dr Ryan Noach explains why they could not fund a valve implant called a Xen stent for a glaucoma patient.
Stop Stock Outs Project manager Kopano Klass explains the investigation they did to unearth this shortage of medicines.
